期刊文献+

某院药师协议处方制度的构建与实践探索 被引量:13

Construction of Pharmacist Supplementary Prescribing System In A Hospital
原文传递
导出
摘要 目的在某院初步建立药师协议处方制度。方法设立慢性阻塞性肺疾病药学专科门诊,通过建立呼吸专科医师与临床药师联合工作模式,在起始治疗由医师拟定治疗方案的基础上,药师负责稳定期患者的后续管理。结果药师开具的处方数量从2018年5~7月期间逐月增加,协议处方中以药物处方为主,占协议处方总数的94%。结论该院建立的慢性阻塞性肺疾病专科药师协议处方制度是切实可行的,值得进一步推广。 OBJECTIVE Explore the pharmacist supplementary prescribing system in a hospital.METHODS By establishment collaborative drug therapy management between pharmacists and physicians in stable chronic obstructive pulmonary disease (COPD), RESULTS The number of the pharmacist supplementary,prescribing was increasing from May to July,2018,and drug prescription was 94 percent in all supplementary prescribing.CONCLUSION The pharmacist supplementary prescribing system on outpatients of COPD in our hospital is practical and should be promoted.
作者 喻鹏久 谭涵梦 刘亮辉 魏毅 郑志华 陈荣昌 魏理 YU Pengjiu;TAN Hanmeng;LIU Lianghui;WEI Yi;ZHENG Zhihua;CHEN Rongchang;WEI Li(Pharmacy Department of First Affiliated Hospital,Guangzhou Medical University,Guangzhou,Guangdong 510120,China;Pharmacy College,Guangzhou Medical University,Guangzhou ,Guangdong511436,China;Guangdong Pharmaceutical Association,Guangzhou,Guangdong 510080,China;Guangzhou Institute of Respiratory Diseases,Guangzhou Medical University,Guangzhou,Guangdong 510120,China)
出处 《今日药学》 CAS 2018年第11期749-751,共3页 Pharmacy Today
关键词 药师协议处方 合作药物治疗管理 临床药师 慢性阻塞性肺疾病 pharmacist supplementary prescribing collaborative drug therapy management clinical pharmacist chronic obstructive pulmonary disease
  • 相关文献

参考文献8

二级参考文献87

  • 1柳涛,蔡柏蔷.一种新型的生活质量评估问卷:慢性阻塞性肺疾病评估测试[J].中国医学科学院学报,2010,32(2):234-238. 被引量:161
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8229
  • 3Hammond RW, Schwartz AH, Campbell M J, et al. American College of Clinical Pharmacy. Collaborative Drug Therapy Management by Pharmacists-2003. Pharmacotherapy[J], 2003 ;23(9): 1210-1225.
  • 4Schommer JC, Planas LG, Johnson KA, et al. Pharmacist-provided medication therapy management (part 1): Payer perspectives in 2007[J]. J Am Pharm Assoc. 2008;48:354-363.
  • 5Schommer JC,Planas LG,Johnson KA, et al. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007[J]. J Am Pharm Assoc. 2008;48:478-486.
  • 6Snella KA, Trewyn RR, Hansan LB, et al. Pharmacist compensation for cognitive services: Focus on the physician office and community pharmacy[J]. Pharmacotherapy; 2004; 24(3): 372-388.
  • 7唐金陵,王杉.临床证据[M]精华版.北京:北京大学医学出版社,2008:400-401.
  • 8Jones PW,Harding G,Berry P,et al.Development and first validation of the COPD Assessment Test.Eur Respir J,2009,34:648 -654.
  • 9Rabe KF,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary.Am J Respir Crit Care Med,2007,176:532-555.
  • 10Jones P,Harding G,Wiklund I,et al.Improving the process and outcome of care in COPD:development of a standardised assessment tool.Prim Care Respir J,2009,18:208-215.

共引文献417

同被引文献105

引证文献13

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部